Literature DB >> 15790932

Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies.

Ryo Sugano1, Hidehiro Matsuoka, Nobuya Haramaki, Hidekazu Umei, Eiko Murase, Kei Fukami, Shuji Iida, Hisao Ikeda, Tsutomu Imaizumi.   

Abstract

OBJECTIVES: To examine whether polymorphonuclear leukocytes (PMNs) in hypercholesterolemia (HC) are activated to generate large amount of superoxide in vivo and hence impair endothelial function and, if so, whether statins, which possess anti-inflammatory properties, may restore PMN-mediated endothelial dysfunction. METHODS AND
RESULTS: At baseline, subjects with HC showed impaired endothelial function (P<0.001), estimated by flow-mediated vasodilation of the brachial artery, and increased susceptibility of low-density lipoprotein (LDL) to oxidation (P<0.0001) compared with control subjects. PMNs obtained from HC produced greater amount of superoxide (P<0.0001), showed higher adhesiveness to cultured endothelial cells (HUVECs) (P<0.0001), and impaired endothelial nitric oxide synthase (eNOS) Ser1177 phosphorylation of HUVECs compared with controls (P<0.001). Crossover administration of fluvastatin or colestimide for 3 months lowered LDL to the same levels (P<0.001 for both). Endothelial function was restored (P<0.0001). LDL oxidation (P<0.0001) and superoxide release from PMNs (P<0.0001) were diminished only in fluvastatin but not in colestimide arm. Fluvastatin attenuated PMN adhesion to HUVECs (P<0.0001) and restored eNOS Ser1177 phosphorylation of HUVECs (P<0.001).
CONCLUSIONS: Statins may improve endothelial function at least in part by inactivating neutrophils independently of LDL reduction. Our results raise a novel concept that polymorphonuclear leukocytes may attack endothelia and play a pivotal role in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790932     DOI: 10.1161/01.ATV.0000163842.91226.ba

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Myeloid-specific Krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis.

Authors:  Jerry B Lingrel; Robyn Pilcher-Roberts; Joshua E Basford; Palanikumar Manoharan; Jon Neumann; Eddy S Konaniah; Ramprasad Srinivasan; Vladimir Y Bogdanov; David Y Hui
Journal:  Circ Res       Date:  2012-04-03       Impact factor: 17.367

2.  Prooxidative effects of aspartame on antioxidant defense status in erythrocytes of rats.

Authors:  Marko D Prokic; Milica G Paunovic; Milos M Matic; Natasa Z Djordjevic; Branka I Ognjanovic; Andras S Stajn; Zorica S Saicic
Journal:  J Biosci       Date:  2014-12       Impact factor: 1.826

3.  Membrane cholesterol is a biomechanical regulator of neutrophil adhesion.

Authors:  Hana Oh; Emile R Mohler; Aiwei Tian; Tobias Baumgart; Scott L Diamond
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-10       Impact factor: 8.311

4.  Hypercholesterolaemic serum increases the permeability of endothelial cells through zonula occludens-1 with phosphatidylinositol 3-kinase signaling pathway.

Authors:  Chang Bian; Geng Xu; Jianan Wang; Ji Ma; Meixiang Xiang; Peng Chen
Journal:  J Biomed Biotechnol       Date:  2010-01-27

5.  Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea.

Authors:  Luigina Guasti; Franca Marino; Marco Cosentino; Lorenzo Maroni; Andrea M Maresca; Fausto Colombo; Ramona C Maio; Luana Castiglioni; Federica Saporiti; Anna Loraschi; Giovanni Gaudio; Antonella Bernasconi; Emanuela Laurita; Anna M Grandi; Achille Venco
Journal:  Sleep Breath       Date:  2009-11-19       Impact factor: 2.816

Review 6.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

7.  Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins.

Authors:  Issam Zineh; Amber L Beitelshees; Gregory J Welder; Wei Hou; Nasser Chegini; Jun Wu; Sharon Cresci; Michael A Province; John A Spertus
Journal:  PLoS One       Date:  2008-09-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.